https://majorhealthnews.com/press-releases/aligos-therapeutics-reports-recent-business-progress-and-third-quarter-2026-financialMajor Health Newsen2026-11-06T13:06:49.036ZAligos Therapeutics Reports Recent Business Progress and Third Quarter 2026 Financial Results https://majorhealthnews.com/press-releases/vtv-therapeutics-reports-third-quarter-2026-financial-results-and-provides-corporateMajor Health Newsen2026-11-05T21:39:16.612ZvTv Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update https://majorhealthnews.com/press-releases/pyxis-oncology-reports-third-quarter-2026-financial-results-and-highlights-progressMajor Health Newsen2026-11-05T12:47:31.176ZPyxis Oncology Reports Third Quarter 2026 Financial Results and Highlights Progress Toward Pivotal Development of Micvotabart Pelidotin (MICVO)